Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-17 | 2024-02-29 | 216290 |
| TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-20 | 2024-04-07 | 222839 |
| QUETIAPINE FUMARATE XR | 50MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223344 |
| QUETIAPINE FUMARATE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-25 | 2024-04-14 | 223281 |
| QUETIAPINE FUMARATE XR | 200MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223380 |
| QUETIAPINE FUMARATE XR | 300MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223365 |
| QUETIAPINE FUMARATE XR | 400MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223373 |
| ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-27 | 2024-05-08 | 223485 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-26 | 223456 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-27 | 223453 |
| DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-25 | 2024-04-19 | 223265 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2024-03-02 | 79600 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2024-04-10 | 2024-04-11 | 224800 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-06 | 2018-09-28 | 12095 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-09-28 | 21989 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-14 | 2024-02-27 | 103271 |
| ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-10-01 | 2018-10-31 | 62783 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |